Regulatory News Service

2CRSi SA: Combined Shareholders’ Meeting to be held on 30 November 2023 Update on forthcoming announcements

Retrieved on: 
Tuesday, October 17, 2023
ISIN, Acquisition, Regulatory News Service, Combined, Security (finance), Airline

Strasbourg (France), 05 October 2023 - 2CRSi (ISIN: FR0013341781), designer and manufacturer of high-performance, energy-efficient servers, announces that its next Combined Shareholders’ Meeting will be held on 30 November 2023.

Key Points: 
  • Strasbourg (France), 05 October 2023 - 2CRSi (ISIN: FR0013341781), designer and manufacturer of high-performance, energy-efficient servers, announces that its next Combined Shareholders’ Meeting will be held on 30 November 2023.
  • The Combined Shareholders’ Meeting, originally scheduled for 31 August 2023 and postponed on 11 August 2023 , is now scheduled for 30 November 2023.
  • All documents relating to this Combined Shareholders’ Meeting will be available online on the company's investor portal ( https://investors.2crsi.com/en/welcome-2/ ) from Wednesday 15 November 2023 at the latest.
  • To remedy the financial communication problems encountered, the company's management will propose a new financial year-end date at an extraordinary shareholders' meeting.

Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023

Retrieved on: 
Tuesday, October 17, 2023
Quotient, MAR, EBITDA, Forecasting, COVID-19, Regulatory News Service, Sartorius AG, Pharmaceutical industry, Cryptocurrency

The preliminary underlying EBITDA declined as a result of the volume development and product mix effects to 594 million euros (PY: 912 million euros).

Key Points: 
  • The preliminary underlying EBITDA declined as a result of the volume development and product mix effects to 594 million euros (PY: 912 million euros).
  • Sartorius Stedim Biotech will publish the full set of the 9-month figures for 2023 as scheduled on October 19, 2023.
  • Sartorius Stedim Biotech publishes alternative performance measures that are not defined by international accounting standards.
  • Furthermore, Sartorius Stedim Biotech reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided.

2CRSi SA: 2CRSi joins the exclusive club of high-performance server manufacturers for next generation AI

Retrieved on: 
Tuesday, October 17, 2023
Content delivery network, Intelligence, Automation, AI, SXM, Artificial intelligence, AMD, OAM, ISIN, LLM, Regulatory News Service, HGX, Information technology, Video game, NVIDIA

2CRSi joins the exclusive club of high-performance server manufacturers for next generation AI.

Key Points: 
  • 2CRSi joins the exclusive club of high-performance server manufacturers for next generation AI.
  • Servers dedicated to AI, highly dense, generating heat, and consuming significant amount of energy, is where 2CRSi excels, thanks to its innovative designs and cooling techniques.
  • With this technically highly complex solution, 2CRSi joins the exclusive club of manufacturers capable of integrating technologies from OAM or SXM integrators such as NVIDIA.
  • Deliveries will start in November 2023, and will run until February 2024, depending on chip deliveries from NVIDIA.

Chester County Solid Waste Authority Chooses Waga Energy to Produce RNG at the LLARC Landfill

Retrieved on: 
Tuesday, October 17, 2023
RNG, United States Environmental Protection Agency, Carbon, Gasoline, EPA, Renewable natural gas, Methane, Euronext Paris, Regulatory News Service, Municipal solid waste, Landfill, Natural gas, Oil

Waga Energy (Euronext Paris: FR0012532810; EPA: WAGA), a global expert in the production of Renewable Natural Gas (RNG) from landfills, signed a commercial agreement with the Chester County Solid Waste Authority to produce RNG at its Lanchester Landfill and Reclamation Center (LLARC) site, located in Narvon, PA, USA.

Key Points: 
  • Waga Energy (Euronext Paris: FR0012532810; EPA: WAGA), a global expert in the production of Renewable Natural Gas (RNG) from landfills, signed a commercial agreement with the Chester County Solid Waste Authority to produce RNG at its Lanchester Landfill and Reclamation Center (LLARC) site, located in Narvon, PA, USA.
  • As part of this agreement, Waga Energy will fund the construction of an RNG facility using its patented WAGABOX® technology, to upgrade landfill gas into pipeline-quality RNG.
  • Waga Energy will operate the facility for an initial 20-year term, sharing revenues with Chester County Solid Waste Authority, an intergovernmental solid waste management agency which operates the LLARC site.
  • By implementing the best-in-class landfill gas upgrading technology, the LLARC RNG WAGABOX® will reduce greenhouse gas emissions while generating additional revenues.”

Kosmos Energy to Host Third Quarter 2023 Results and Webcast on November 6, 2023

Retrieved on: 
Friday, October 6, 2023
Oil, Gas, Energy, KOS, Business Wire, Kosmos Energy, Webcast, Telephone, Regulatory News Service, Conference, EST

Kosmos Energy (NYSE/LSE: KOS) announced today the following schedule for its third quarter 2023 results:

Key Points: 
  • Kosmos Energy (NYSE/LSE: KOS) announced today the following schedule for its third quarter 2023 results:
    Earnings Release: Monday, November 6, 2023, pre-UK market open via Business Wire, Regulatory News Service, and the Company’s website at www.kosmosenergy.com .
  • Conference Call: Monday, November 6, 2023, at 11:00 a.m. EST.
  • The call will be available via telephone and webcast.

Charwood Energy: Charwood Energy acquires a stake in LG Concept, a major regional player in the supply of renewable biomass

Retrieved on: 
Wednesday, October 4, 2023
Regulatory News Service, ISIN, Maintenance, Forestry, Biomass, Ticker, Carbon, Renewable energy

Charwood Energy: Charwood Energy acquires a stake in LG Concept, a major regional player in the supply of renewable biomass

Key Points: 
  • Charwood Energy: Charwood Energy acquires a stake in LG Concept, a major regional player in the supply of renewable biomass
    Dissemination of a French Regulatory News, transmitted by EQS Group.
  • Charwood Energy acquires a stake in LG Concept, a major regional player in the supply of renewable biomass
    Charwood Energy (ISIN: FR001400AJ60, Ticker: ALCWE), a French specialist in customized energy recovery solutions, has acquired a 40% stake in LG Concept, a major regional player in renewable biomass supply for boiler rooms in Brittany and the neighboring regions.
  • Adrien Haller, CEO and founder of Charwood Energy, said: “This strategic equity investment is consistent with our objective to control our supply of renewable biomass.
  • LG Concept is a well-established regional player in the region that responds to our clients' energy challenges.

BILENDI: Bilendi awarded by the Market Research Society for its worldwide research project with Harvard and Zurich Universities

Retrieved on: 
Monday, October 2, 2023
Culminating project, Communication, University of Zurich, Partnership, University, Prevalence, Harvard University, Internet, ISO, Professional, COVID-19, TISP, Data collection, Research, Language, CAPI, Certification, Computer-assisted personal interviewing, Trust, Regulatory News Service, Pharmaceutical industry, Risk management, Science

Paris, October 2nd, 2023 - Bilendi was awarded with a highly commended award for the best data collection solution of the year for quantitative research given by the British Market Research Society, for the project “Trust in Science and Science-related Populism” (TISP).

Key Points: 
  • Paris, October 2nd, 2023 - Bilendi was awarded with a highly commended award for the best data collection solution of the year for quantitative research given by the British Market Research Society, for the project “Trust in Science and Science-related Populism” (TISP).
  • TISP is a huge multi-country research project running in 68 countries in partnership with respected researchers from Harvard University and the University of Zurich .
  • To answer these questions, Dr. Viktoria Cologna (Harvard University) and Dr. Niels G. Mede (University of Zurich) envisioned the TISP project.
  • According to the TISP Project Leads, “Bilendi was particularly suited to the project due to its professionalism, high-quality standards, academic experience, and international project management capabilities”.

2CRSi SA: 2CRSi signs a contract with Lawrence Livermore National Lab

Retrieved on: 
Monday, October 2, 2023
Lawrence Livermore National Laboratory, Science, Regulatory News Service, Sun, Intelligence, Safety, LLNL, Immersion

Strasbourg (France), October 2, 2023 - 2CRSi, designer and manufacturer of high-performance, energy-efficient computer servers, announces the signing of an order with the Lawrence Livermore National Laboratory to equip immersion servers.

Key Points: 
  • Strasbourg (France), October 2, 2023 - 2CRSi, designer and manufacturer of high-performance, energy-efficient computer servers, announces the signing of an order with the Lawrence Livermore National Laboratory to equip immersion servers.
  • For more than 70 years, Lawrence Livermore National Laboratory (LLNL), whose mission is to ensure the safety, security, and reliability of the U.S. nuclear deterrent, has leveraged science and technology to achieve breakthroughs in national security, climate resilience, counterterrorism, defense, intelligence, and energy security.
  • Now, equipped with servers using direct liquid cooling solutions, LLNL has chosen 2CRSi to test immersion cooling technology.
  • At the end of this test phase, the collaboration between 2CRSi and Lawrence Livermore National Laboratory could be extended with additional orders over several years.

VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes

Retrieved on: 
Monday, October 2, 2023
Volunteering, Communication, Partnership, American Diabetes Association, European Association for the Study of Diabetes, Research and development, Development, EASD, Regulatory News Service, Congress, Research, Prediabetes, Phase, ADA, Industrial Affairs Committee (Iceland), Pharmaceutical industry, Diabetes

VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes

Key Points: 
  • VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes
    Dissemination of a French Regulatory News, transmitted by EQS Group.
  • Valbiotis: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes
    The Phase II/III clinical study REVERSE-IT, carried out with the active substance TOTUM•63, in partnership with Nestlé Health Science, will be presented on October 3, during an oral communication at the congress of the European Association for the Study of Diabetes (EASD) 2023.
  • This communication will detail the protocol of the REVERSE-IT study, against early glycemic disorders, as well as the complete characteristics of the population included (636 volunteers), at the beginning of the study.
  • “The success of the REVERSE-IT study constitutes a breakthrough for a non-drug approach to prediabetes and untreated early stages of type 2 diabetes.

Affluent Medical : H1 2023 results. Major advances in clinical programs. Extension of cash horizon to February 2024.

Retrieved on: 
Thursday, September 28, 2023
Artus, NYHA, US Foods, Urinary incontinence, Disease, Human, Statutory auditor, Tricuspid valve, Myocardial infarction, DSMB, Butterfly valve, Hospital, Boston Scientific, Bank statement, Abbott, Anatomy, Aortic stenosis, Food, Clinical trial, Optimization, Quality of life, Minerva, MR, Kalio, Doctor of Philosophy, TAVI, New York Heart Association Functional Classification, Medtronic, Mitral regurgitation, MD, Patient, Mitral valve, Risk, Data, CEST, Engineering, Regulatory News Service, ISIN, DSM-IV codes, Neurostimulation, FDA, Death, Aix-en-Provence, III, Medtech, Pharmaceutical industry, Medical imaging, Medical device, Nursing, Fine chemical, Science

Since early 2023, Affluent Medical has been developing its medical devices and announced important clinical advances in each of its three programs.

Key Points: 
  • Since early 2023, Affluent Medical has been developing its medical devices and announced important clinical advances in each of its three programs.
  • This transcatheter approach avoids an invasive "open heart" procedure and associated complications to treat mitral valve insufficiency.
  • Affluent Medical believes that Kalios would avoid further intervention for potentially 30-40% of patients over a five-year horizon.
  • This transaction would be intended to finance ongoing clinical programs and could receive the support of its reference shareholders.